Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data-Reference-Cited by-同舟云学术

Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data

Published:2010-02-04 Issue:1 Volume:8 Page:
ISSN:1546-0096
Container-title:Pediatric Rheumatology
language:en
Short-container-title:Pediatr Rheumatol

Author:

Levy Deborah M,Imundo Lisa F

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1186/1546-0096-8-7.pdf

Reference52 articles.

1. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR: Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA. 1999, 96 (13): 7563-8. 10.1073/pnas.96.13.7563.

2. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000, 284 (10): 1247-55. 10.1001/jama.284.10.1247.

3. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000, 343 (21): 1520-8. 10.1056/NEJM200011233432103.

4. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M: Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005, 352 (11): 1071-80. 10.1056/NEJMoa050405.

5. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005, 352 (11): 1081-91. 10.1056/NEJMoa050330.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Anti-inflammatory, Antipyretic and Analgesic Activities of Citrullus colocynthis in Albino Rats through in vivo and Pharmacoinformatics Studies;Recent Advances in Anti-Infective Drug Discovery;2024-08

2. Evolution of pediatric gastrointestinal ulcer disease: Is acute surgical intervention relevant?;Journal of Pediatric Surgery;2021-10

3. Dynamics on the field: a focused study on the culture and context of pediatric pain management at four Ghanaian hospitals;BMC Pediatrics;2020-11-20

4. Comparison of Regularly Scheduled Ibuprofen Versus “Pro Re Nata” for Ankle Sprains in Children Treated in the Emergency Department;Pediatric Emergency Care;2020-10-15

5. EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents;Pediatric Allergy and Immunology;2018-06-13